ARTICLE | Distillery Therapeutics
Cardiovascular
April 24, 2018 10:46 PM UTC
Patient sample and rat studies suggest inhibiting CD126 could help treat pulmonary arterial hypertension (PAH). In lung samples from lung transplant patients with idiopathic PAH or in a rat model of P...
BCIQ Company Profiles
BCIQ Target Profiles